Business Description
Bausch & Lomb Corp
NAICS : 333314
SIC : 3912
ISIN : CA0717051076
Description
Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.71 | |||||
Debt-to-EBITDA | 8.75 | |||||
Interest Coverage | 0.51 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.91 | |||||
Beneish M-Score | -2.55 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.3 | |||||
3-Year EBITDA Growth Rate | -10.7 | |||||
3-Year EPS without NRI Growth Rate | -89.2 | |||||
3-Year Book Growth Rate | -10.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.55 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.18 | |||||
9-Day RSI | 55.5 | |||||
14-Day RSI | 54.01 | |||||
6-1 Month Momentum % | -1.27 | |||||
12-1 Month Momentum % | -9.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.65 | |||||
Quick Ratio | 1.01 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 191.18 | |||||
Days Sales Outstanding | 69.91 | |||||
Days Payable | 85.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -36.13 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.84 | |||||
Operating Margin % | 4.26 | |||||
Net Margin % | -10.17 | |||||
FCF Margin % | -3.05 | |||||
ROE % | -6.79 | |||||
ROA % | -3.56 | |||||
ROIC % | 2.86 | |||||
3-Year ROIIC % | 15.87 | |||||
ROC (Joel Greenblatt) % | 5.52 | |||||
ROCE % | 1.04 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 18.55 | |||||
PS Ratio | 1.26 | |||||
PB Ratio | 0.85 | |||||
Price-to-Operating-Cash-Flow | 46.81 | |||||
EV-to-EBIT | 85.36 | |||||
EV-to-Forward-EBIT | 30.57 | |||||
EV-to-EBITDA | 18.79 | |||||
EV-to-Forward-EBITDA | 14.13 | |||||
EV-to-Revenue | 2.24 | |||||
EV-to-Forward-Revenue | 1.48 | |||||
EV-to-FCF | -73.35 | |||||
Earnings Yield (Greenblatt) % | 1.17 | |||||
FCF Yield % | -2.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BLCO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bausch & Lomb Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 4,495 | ||
EPS (TTM) ($) | -1.3 | ||
Beta | 0 | ||
Volatility % | 40.81 | ||
14-Day RSI | 54.01 | ||
14-Day ATR ($) | 0.521219 | ||
20-Day SMA ($) | 15.9655 | ||
12-1 Month Momentum % | -9.03 | ||
52-Week Range ($) | 13.16 - 17.94 | ||
Shares Outstanding (Mil) | 351.9 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bausch & Lomb Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bausch & Lomb Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Bausch & Lomb Corp Frequently Asked Questions
What is Bausch & Lomb Corp(BLCO)'s stock price today?
The current price of BLCO is $15.89. The 52 week high of BLCO is $17.94 and 52 week low is $13.16.
When is next earnings date of Bausch & Lomb Corp(BLCO)?
The next earnings date of Bausch & Lomb Corp(BLCO) is 2024-11-01 Est..
Does Bausch & Lomb Corp(BLCO) pay dividends? If so, how much?
Bausch & Lomb Corp(BLCO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |